| 摘要 |
The present invention provides novel analogues of glucagon-like protein-1 (GLP-1) receptor agonist peptides that are capable of promoting cholesterol efflux. The present invention also provides compositions comprising the novel glucagon-like protein-1 (GLP-1) receptor analogues, and relates to and to the use of said compounds in the manufacture of medicaments, the the use of said compounds in therapy, and to methods of treatment comprising administration of said compounds to patients. |
